Skip to content

Generate Biomedicines, Inc. GENB Other Non-Current Assets

Other Non-Current Assets at other companies

MYR Group logo
MYR GroupMYRG
$9.2M+50.0%
SSR Mining logo
SSR MiningSSRM
$60.86M-24.3%
Repligen logo
RepligenRGEN
$5.88M+178%
ST
Sensata TechnologiesST
$138.6M+21.1%
LKQ logo
LKQLKQ
$414M+8.9%
AppFolio logo
AppFolioAPPF
$15.25M+14.4%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's other non-current assets?
Generate Biomedicines, Inc. (GENB) reported other non-current assets of $4.75M in Q1 2026.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.